Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$2.34 USD
-0.02 (-0.64%)
Updated May 10, 2024 03:57 PM ET
After-Market: $2.32 -0.02 (-0.64%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/10/24 |
---|---|
Current Quarter | -0.64 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | 18.18% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.60 |
Next Year | -2.93 |
EPS (TTM) | -1.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.47M | 0.33M | 0.80M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.64 | -0.63 | -2.60 | -2.93 |
# of Estimates | 2 | 2 | 4 | 3 |
Most Recent Consensus | -0.60 | -0.60 | -2.37 | -2.87 |
High Estimate | -0.60 | -0.60 | -2.36 | -2.60 |
Low Estimate | -0.67 | -0.66 | -2.97 | -3.31 |
Year ago EPS | -0.48 | -0.62 | -1.91 | -2.60 |
Year over Year Growth Est. | -33.33% | -1.61% | -36.13% | -12.76% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.64 | -0.63 | -2.60 | -2.93 |
7 Days Ago | -0.64 | -0.63 | -2.60 | -2.93 |
30 Days Ago | -0.64 | -0.63 | -2.60 | -2.93 |
60 Days Ago | -0.63 | -0.62 | -2.82 | -3.19 |
90 Days Ago | -0.63 | -0.62 | -2.82 | -3.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.64 | -0.63 | -2.60 | -2.93 |
Zacks Consensus Estimate | -0.64 | -0.63 | -2.60 | -2.93 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.37 | -0.62 | -0.48 | NA |
Estimate | -0.55 | -0.62 | -0.59 | -0.58 | NA |
Difference | 0.10 | 0.25 | -0.03 | 0.10 | 0.11 |
Surprise | 18.18% | 40.32% | -5.08% | 17.24% | 17.67% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more